Navigation Links
Dealing with power outages more efficiently
Date:11/7/2012

Power supply is the backbone of our modern economy. Nearly every aspect of life depends on electrically-operated devices. When the flow of power stops, it is not just the lights that go out. In the supermarket, the automatic teller machines and cash registers stop working. Even telephones, radios and televisions become paralyzed. If the shortage lasts a long time the supply of hot water, gas and fuel and the functioning of respirators at intensive care units in nursing homes or at private homes is at risk.

The causes of this dreadful scenario can range from natural disasters to terrorist attacks or just technical problems. A few recent examples demonstrate how real the risk is in Germany where the last major event occurred in Hannover in 2011. The 650,000 people there went without power for up to 90 minutes after a blockage in a coal-fired power plant, and the power main connection at a transformer station failed. Even more far-reaching consequences were seen from the biggest power outage in post-war history, when extreme snowfalls in the Mnsterland region in 2005 knocked out a series of high-voltage pylons. Some 250,000 people went without power, in some cases for up to five days. The financial damages exceeded 100 million euros.

Firefighters as process managers

In emergency cases, the utility companies, public officials and emergency services realize that they must contend with a variety of tasks: Who are the most seriously affected? Where is greatest need for action? How long will emergency power supply last? Who travels where, and how long will the fuel last? Theseare just a fraction of the issues that require rapid response. "To minimize the duration of the crash, the officers-in-charge at the fire, police and emergency services departments have to act like process managers," explains Dr. Thomas Rose, head of the Risk Management and Decision Support research department at the Fraunhofer Institute for Applied Information Te
'/>"/>

Contact: Prof. Dr. Thomas Rose
thomas.rose@fit.fraunhofer.de
49-224-114-2798
Fraunhofer-Gesellschaft
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Stem cell research paves way for progress on dealing with Fragile X retardation
2. Heart-powered pacemaker could one day eliminate battery-replacement surgery
3. MIT research: The power of being heard
4. Green Oakley Cluster to double OSC computing power
5. Powerful sequencing technology decodes DNA folding pattern
6. The power of broccoli, in a capsule
7. Folding light: Wrinkles and twists boost power from solar panels
8. New study discovers powerful function of single protein that controls neurotransmission
9. Powerful new approach to attack flu virus
10. UTMB researchers create powerful new method to analyze genetic data
11. Pitcher plant uses power of the rain to trap prey
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Dealing with power outages more efficiently
(Date:3/5/2015)... 5, 2015 In Brazil , ... already using these solutions and 42 percent planning to invest ... approximately 25 percent of the companies will be investing in ... majority of companies in the region are currently opting for ... model will command significant attention in the coming years. This ...
(Date:3/4/2015)... Mar. 04, 2015 Research and Markets ... of the "Global Biometrics Market Forecast and ... The market for biometric authentication systems is ... 14% till 2020 The driving forces ... security needs, government projects and constant development in ...
(Date:3/3/2015)... , March 3, 2015 ... provider of advanced cryogenic logistics solutions for ... immunotherapies, stem cells, cell lines, clinical research ... medicine, today announced the expansion of its ... Centers, ("Fred Hutch") Clinical Research Division ...
Breaking Biology News(10 mins):Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3
... the University of Leicester has proposed an immense (1.5km) exhibition ... a vivid perspective of how quickly human activity is changing ... at a rate of a few centimetres every thousand years. ... vertically down into the sea bed to extract a sample ...
... 1 The U.S. Department of Homeland,Security ... collecting additional,fingerprints from international visitors arriving at ... change is part of the,department,s upgrade from ... facilitate legitimate travel by more accurately and,efficiently ...
... Mouse and rat brain atlases have long ... traditional brain atlases offer an incomplete map ... Reference Atlas: A Digital Color Brain Atlas ... Edition; January 2008; $195.00; 376 Pages; Paperback; ...
Cached Biology News:DHS Begins Collecting 10 Fingerprints From International Visitors at George Bush Houston Intercontinental Airport 2Book is the first high-resolution digital mouse brain atlas designed for Web applications 2
(Date:3/6/2015)... Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a ... release its full financial results for the fourth quarter and ... after market close, followed by a conference call at ... outlook. Participants should call (888) 243-4451 ( ... the InspireMD call. A live webcast of the call will ...
(Date:3/6/2015)... According to a new market ... patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments) ... augmentation) - Global Forecast to 2019", published by MarketsandMarkets, ... $14.7 Billion in 2019 from $10.3 Billion in 2014, ... 2019. Browse 70 market data tables ...
(Date:3/6/2015)... 06, 2015 AACC International unveiled ... for the grain scientists’ Centennial Meeting and also ... 2015 marks the 100th anniversary of AACC International ... Minneapolis, Minnesota, U.S.A. on October 18-21, 2015. The ... who are looking to the next 100 years ...
(Date:3/6/2015)... 6, 2015  Attorney Advertising-- Bronstein, Gewirtz & Grossman, ... purchasers of the securities of Orexigen Therapeutics, Inc. ... -News).  Such investors are advised to contact ... coordinator Eitan Kimelman at info@bgandg.com ... whether Orexigen and certain of its officers and/or ...
Breaking Biology Technology:InspireMD to Report Financial Results for the Fourth Quarter and Year Ended December 31, 2014 on Thursday, March 12th 2Soft Tissue Repair Market worth $14.7 Billion in 2019 2Soft Tissue Repair Market worth $14.7 Billion in 2019 3Soft Tissue Repair Market worth $14.7 Billion in 2019 4AACCI Unveils Scientific Symposia Sessions for Centennial Meeting 2SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Orexigen Therapeutics, Inc. 2
... , May 17 Sigma-Aldrich Corporation (Nasdaq: SIAL ) will ... 20th at 1:15 PM CDT ( 2:15 PM EDT ) ... over the Internet available at http://investor.sigmaaldrich.com/ .  Users can click the "Webcast" ... , , ...
... May 17 TriReme Medical, Inc. (TMI) announced today that ... for its GliderXtreme™ PTA balloon catheter. GliderXtreme™ is now approved for ... balloon diameters from 2.0 – 5.0mm and in balloon lengths up ... , ...
... 17 ViroPharma Incorporated (Nasdaq: VPHM ) today ... Cinryze™ (C1 Esterase Inhibitor [Human]) in preventing and treating attacks ... Health,s online clinical trial registry, www.clinicaltrials.gov . The data ... data from the CHANGE 2 acute treatment study will be ...
Cached Biology Technology:Sigma-Aldrich Corporation to Present at the Baird's 2010 Growth Stock Conference on Thursday, May 20, 2010 2TriReme Medical, Inc. Receives FDA 510(k) Clearance for a Broad Matrix of GliderXtreme(TM) PTA Balloon Catheter Sizes 2ViroPharma Announces Availability of Cinryze(TM) (C1 Esterase Inhibitor [Human]) Final Open-Label Data 2ViroPharma Announces Availability of Cinryze(TM) (C1 Esterase Inhibitor [Human]) Final Open-Label Data 3ViroPharma Announces Availability of Cinryze(TM) (C1 Esterase Inhibitor [Human]) Final Open-Label Data 4ViroPharma Announces Availability of Cinryze(TM) (C1 Esterase Inhibitor [Human]) Final Open-Label Data 5ViroPharma Announces Availability of Cinryze(TM) (C1 Esterase Inhibitor [Human]) Final Open-Label Data 6ViroPharma Announces Availability of Cinryze(TM) (C1 Esterase Inhibitor [Human]) Final Open-Label Data 7
Mouse polyclonal antibody to PRDM2 - PR domain containing 2, with ZNF domain...
Hepatocyte Differentiation Environment...
Mouse monoclonal [M2II-12] to MRP2 ( Abpromise for all tested applications). entrezGeneID: 1244 SwissProtID: Q92887...
...
Biology Products: